SCHEMBL2476525

SCHEMBL2476525

CC(=O)c1cc(Cl)cc(Br)c1OC(=S)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 2/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 7/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
POLB P06746 1/20 0.32
RECQL P46063 1/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 2/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9929102 0.77 HSD17B10 (0.50) MAPTRAB9AMAOAMAOBKMT2A
SCHEMBL13159045 0.71 ALDH1A1 (0.40) MAPTRAB9ANPC1NPSR1LMNA
SCHEMBL11616119 0.71 HSD17B10 (0.38) MAPTRAB9ANPC1NPSR1LMNA
SCHEMBL24215372 0.71 RAB9A (0.41) MAPTRAB9ANPC1NPSR1LMNA
SCHEMBL220153 0.71 MAOA (0.40) LMNAMAOAMAOBKMT2AALDH1A1
SCHEMBL11822691 0.70 L3MBTL1 (0.52) RAB9ANPC1NPSR1LMNAKMT2A
SCHEMBL3493073 0.69 PTGDR2 (0.54) MAPTRAB9ANPC1NPSR1MAOA
SCHEMBL9740369 0.68 RAB9A (0.37) MAPTRAB9ANPC1NPSR1LMNA
SCHEMBL2469290 0.68 MAOA (0.40) MAPTMAOAMAOBALDH1A1HPGD
SCHEMBL221422 0.68 MAOA (0.49) MAPTLMNAMAOAMAOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370422-B1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN INC (US) 2019-06-05 EP disclosed
US-9149476-B2 Thiochromene derivatives as HIF hydroxylase inhibitors FIBROGEN, INC. (US) 2015-10-06 US disclosed
US-20150182528-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN, INC. 2015-07-02 US disclosed
US-8927591-B2 Thiochromene derivatives as HIF hydroxylase inhibitors FIBROGEN, INC. (US) 2015-01-06 US disclosed
US-20110305776-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN, INC. (US) 2011-12-15 US disclosed
CN-102272117-A Benzothiopyran derivatives as HIF hydroxylase inhibitors 2011-12-07 CN disclosed
EP-2370422-A1 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS Fibrogen, Inc. (US) 2011-10-05 EP disclosed
WO-2010056767-A1 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS FIBROGEN, INC. (US) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110305776-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS HIF1AN, HIF1A, EGLN2 MAPT 3686/4885RAB9A 4576/4885NPC1 2671/4885
US-20150182528-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS HIF1AN, HIF1A, EGLN2 MAPT 3686/4885RAB9A 4576/4885NPC1 2671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.